We create value in Life Science

MedCap develops leading niche companies in the life science industry

MedCap acquires and develops profitable, market-leading niche companies in the life science industry in Northern Europe that have the potential to grow internationally. The group conducts operations in two areas: MedTech and Specialty Pharma.

About MedCap

Press releases

Press releases

Calendar

  • Interim report 3 2021

  • Year-end report 2021

  • Interim Report 1 2022

To the calendar
Interrim Report Medcap

Latest interim report

Read MedCaps Interim report for the second quarter 2021. 

To interim reports

Our holdings

The business is conducted in two areas, medical technology and specialist pharmaceuticals. Since 2001, MedCap has completed acquisitions, refinancing and sales.

Abilia barn som kramas

Abilia

Business area:

MedTech

Industry:

Assistive technology for Cognition, Communication, Environmental Control and Alarm

Geographic market:

Nordic, UK and Exports
Cardiolex maskin

Cardiolex

Business area:

MedTech

Industry:

ECG-solutions and software

Geographic market:

Europe
Inpac medicin

Inpac

Business area:

MedTech

Industry:

Contract manufacturing of probiotics and nutrition supplements, and packaging solutions for pharmaceuticals

Geographic market:

Nordic
Multiply maskin

Multi ply

Business area:

MedTech

Industry:

Carbon fiber components for MedTech applications

Geographic market:

Global
Unimedic yoga

Unimedic

Business area:

Specialty Pharma

Industry:

Specialty Pharmaceuticals and CDMO

Geographic market:

Northern Europe
Find out more about holdings
Flygfoto-stockholm

Become a part of MedCap

Here you will find more information about our investment strategy and about MedCap as owner.

Investment strategy MedCap as owner